MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 113 filers reported holding MAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $98 | -38.4% | 31,565 | -9.6% | 0.00% | – |
Q2 2023 | $159 | -58.8% | 34,924 | -55.2% | 0.00% | – |
Q1 2023 | $386 | +132.5% | 77,878 | +154.5% | 0.00% | – |
Q4 2022 | $166 | -99.8% | 30,597 | +172.7% | 0.00% | – |
Q3 2022 | $72,000 | +18.0% | 11,220 | -12.3% | 0.00% | – |
Q2 2022 | $61,000 | -73.8% | 12,792 | -61.5% | 0.00% | – |
Q1 2022 | $233,000 | +870.8% | 33,229 | +1296.2% | 0.00% | – |
Q4 2021 | $24,000 | +60.0% | 2,380 | +95.2% | 0.00% | – |
Q3 2021 | $15,000 | – | 1,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |